BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/26/2022 6:23:37 PM | Browse: 266 | Download: 1007
 |
Received |
|
2022-07-07 12:19 |
|
Peer-Review Started |
|
2022-07-07 12:20 |
|
First Decision by Editorial Office Director |
|
2022-10-27 00:38 |
|
Return for Revision |
|
2022-10-27 00:38 |
|
Revised |
|
2022-11-07 10:44 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-12-02 03:01 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-12-05 08:29 |
|
Articles in Press |
|
2022-12-05 08:29 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-12-07 02:41 |
|
Publish the Manuscript Online |
|
2022-12-26 18:23 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Endobronchial ultrasound-guided transbronchial needle aspiration in intrathoracic lymphadenopathy with extrathoracic malignancy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shi-Jie Li and Qi Wu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Wu Jieping Medical Foundation special fund for clinical research |
320.6750.2021-04-71 |
| Open Research Fund of NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases |
KF202101 |
| Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences |
2020-PT330-003 |
|
| Corresponding Author |
Qi Wu, MD, Associate Chief Physician, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, no.8 fucheng road, haidian district, Beijing, 100142, China., Beijing 100142, China. wuqi1973@bjmu.edu.cn |
| Key Words |
Endobronchial ultrasound; Intrathoracic lymphadenopathy; Extrathoracic malignancy; Transbronchial needle aspiration; Diagnosis |
| Core Tip |
This was a retrospective study of patients referred to Peking University Cancer Hospital from January 2013 to December 2018 for endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) due to intrathoracic lymphadenopathy. The specimens were defined as positive for malignancy, negative for non-malignancy (tuberculosis, sarcoidosis, etc.), and without definite diagnosis. Sensitivity, negative predictive value for malignancy, and overall accuracy were calculated. EBUS-TBNA was found to be a simple and accurate procedure for the diagnosis of intrathoracic lymphadenopathy with extrathoracic malignancy. |
| Publish Date |
2022-12-26 18:23 |
| Citation |
Li SJ, Wu Q. Endobronchial ultrasound-guided transbronchial needle aspiration in intrathoracic lymphadenopathy with extrathoracic malignancy. World J Clin Cases 2022; 10(36): 13227-13238 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i36/13227.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i36.13227 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
